Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma

Clinical trial NCT00334282 · COMPLETED

Trial details

NCT number: NCT00334282
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2006-04-01
Primary completion: 2008-05-01
Enrollment: 435

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.